DXCM DEXCOM INC.

Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.

(NASDAQ:DXCM) today announced that it plans to release its second quarter 2024 financial results after market close on Thursday, July 25, 2024. Management will hold a conference call to review the company's second quarter 2024 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at and will be archived there for future reference.

To listen to the conference call, please dial (877) 344-3040 (US/Canada) or (646) 475-1647 (International) and use the confirmation ID "9430114" approximately five minutes prior to the start time.

About DexCom, Inc.

DexCom, Inc. empowers people to take control of health through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world. For more information about Dexcom CGM, visit .

Category: IR

EN
27/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DEXCOM INC.

 PRESS RELEASE

Dexcom and ŌURA Announce Strategic Partnership

SAN DIEGO & SAN FRANCISCO--(BUSINESS WIRE)-- (NASDAQ:DXCM), the global leader in glucose biosensing, and , maker of the world’s leading smart ring, announced today a strategic partnership to help millions of people improve their metabolic health through the integration of Dexcom glucose data with vital sign, sleep, stress, heart health and activity data from Oura Ring. Combining Dexcom glucose data with the biometrics collected by Oura Ring will provide users of both products with a more complete picture of overall health. Dexcom is also making a $75 million strategic investment in ŌURA Serie...

 PRESS RELEASE

Dexcom Helps People With Diabetes Take the First Step to Discover What...

SAN DIEGO--(BUSINESS WIRE)-- This World Diabetes Day, (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging people with diabetes globally to take the first step to discover what they’re made of. This comes as global data1 shows nearly 70% of people with diabetes say they didn’t know where to begin their health journey when they were first diagnosed, and nearly half said diabetes has limited their ability to pursue a passion or interest. This press release features multimedia. View the full release here: Dexcom is teaming up with its thousands of global brand advo...

 PRESS RELEASE

Dexcom Reports Third Quarter 2024 Financial Results

SAN DIEGO--(BUSINESS WIRE)-- (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights: Revenue grew 2% year-over-year to $994.2 million on a reported basis and 3% year-over-year on an organic1 basis. U.S. revenue declined 2% and international revenue grew 12% on a reported basis and 16% on an organic1 basis, all on a year-over-year basis. GAAP operating income of $152.0 million or 15.3% of revenue, a decrease of 580 basis points compared to the third quarter of 2023. Non-GAAP operating income* of $21...

 PRESS RELEASE

Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness W...

SAN DIEGO--(BUSINESS WIRE)-- (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, in partnership with the nonprofit , are teaming up with author, producer and actress Retta to establish National Glucose Awareness Week from Sept. 23-29, 2024. will help close the glucose knowledge gap and encourage people to take action to own their glucose health. This press release features multimedia. View the full release here: Actress Retta teams up with Dexcom and Beyond Type 2 to establish National Glucose Awareness Week. (Photo: Business Wire) Understand...

 PRESS RELEASE

Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes t...

SAN DIEGO--(BUSINESS WIRE)-- (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of the third season of , the company’s groundbreaking NIL (name, image, likeness) program exclusively for college athletes with diabetes. This press release features multimedia. View the full release here: The Dexcom U 2024 roster consists of 20 athletes who all use Dexcom CGM to monitor their glucose levels and manage their diabetes (Graphic: Dexcom) Heralded by Ad Age as a after its inaugural season in 2022, the 2024 Dexcom U s...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch